Biotech POSITIVE RESULTS FROM TEZSPIRE® (TEZEPELUMAB-EKKO) PHASE 3 WAYPOINT TRIAL HIGHLIGHT RAPID, SUSTAINED EFFECT IN CHRONIC RHINOSINUSITIS WITH NASAL POLYPS March 2, 2025
Food & Beverage Sucraid® (sacrosidase) Oral Solution. Free 4-Day Trial Now Available. The only FDA- approved therapy to treat CSID (Congenital Sucrase-Isomaltase Deficiency) March 2, 2025
Oil & Gas MAJORS MANAGEMENT ANNOUNCES THE ACQUISTION OF FUEL SUPPLY CONTRACTS FROM BLUEBONNET PETROLEUM March 1, 2025
Real Estate MEDIA ADVISORY – GOVERNMENT OF CANADA AND TOWN OF GEORGINA TO MAKE HOUSING-RELATED ANNOUNCEMENT IN GEORGINA March 1, 2025
Mining NEWPORT RECEIVES AUD$748,151 (GROSS)/AUD$523,706 (NET) QUARTERLY ROYALTY PAYMENT March 1, 2025